Friday, November 26, 2021


Cuban vaccine Abdala highly effective in severe Covid-19 cases

Cuban vaccine Abdala highly effective in severe Covid-19 cases

Havana, Sep 22 (Prensa Latina) The Center for Genetic Engineering and Biotechnology (CIGB) reported that the Abdala Covid-19 vaccine is 90 percent effective in seriously ill patients affected by the SARS-CoV-2 virus, as reported by the local press.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

According to the Granma newspaper, the immunogen was granted in July authorization for emergency use, after demonstrating an efficacy of 92.28 percent in the prevention of the disease.

Its effectiveness was announced in the midst of the propagation of the Delta strain of the SARS-CoV-2 virus.

‘Efficacy should not be confused with effectiveness, since the former is determined in the setting of clinical studies, that is, under ideal research conditions; while effectiveness is analyzed in real-life circumstances,’ clarified the general director of the CIGB, Marta Ayala.

Scientists from the CIGB and the Finlay Vaccine Institute, presented recently to the World Health Organization the results of the research developed to formulate, produce, test and apply the Cuban vaccines in order to have them approved by the international organization.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.